Article Details

FDA Puts DM1 Investigational Therapy AOC 1001 on Fast Track

Retrieved on: 2021-10-19 19:06:15

Tags for this article:

Click the tags to see associated articles and topics

FDA Puts DM1 Investigational Therapy AOC 1001 on Fast Track. View article details on hiswai:

Excerpt

Specifically, when cells “read” the mutated DMPK gene, they produce an abnormally long messenger RNA (mRNA) — the intermediary molecule made when ...

Article found on: musculardystrophynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up